This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Initial investigations

Authoring team

Haematology:

  • full blood count - may be anaemic due to malignancy
  • raised white count may indicate cholangitis or underlying malignancy
  • leucopaenia may occur in viral hepatitis
  • reticulocytosis indicates pre-hepatic jaundice
  • prothrombin time - prolonged in chronic liver disease; will return to normal in cholestasis following parenteral vitamin K, 10 mg

Biochemistry:

  • serum transaminases - increased in hepatic jaundice and to a lesser degree, in extrahepatic jaundice
  • serum alkaline phosphatase - raised in extra-hepatic jaundice; hepatic origin confirmed by concomitant rise in gamma glutamyl transferase
  • serum bilirubin - confirms jaundice; used to monitor progress
  • serum albumin and globulin - little change in acute jaundice; albumin decreased and globulin increased in chronic hepatic jaundice

Urinalysis

Stools:

  • pale stools in cholestasis
  • occult blood - suggests carcinoma

Abdominal ultrasound - assesses bile duct dilatation, liver size, liver metastases, portal blood flow, ascites, lymphadenopathy

Chest x-ray - to show primary or secondary tumours, and any irregularity or elevation of the right diaphragm due to enlarged or nodular liver


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.